- Home
- SNAX vs BDRX Comparison
SNAX vs BDRX Comparison
Compare SNAX & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNAX
- BDRX
- Stock Information
- Founded
- SNAX 2017
- BDRX 2000
- Country
- SNAX United States
- BDRX United Kingdom
- Employees
- SNAX N/A
- BDRX N/A
- Industry
- SNAX Packaged Foods
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- SNAX Consumer Staples
- BDRX Health Care
- Exchange
- SNAX Nasdaq
- BDRX Nasdaq
- Market Cap
- SNAX 2.7M
- BDRX 2.4M
- IPO Year
- SNAX N/A
- BDRX N/A
- Fundamental
- Price
- SNAX $0.75
- BDRX $4.28
- Analyst Decision
- SNAX
- BDRX Strong Buy
- Analyst Count
- SNAX 0
- BDRX 1
- Target Price
- SNAX N/A
- BDRX $200.00
- AVG Volume (30 Days)
- SNAX 128.6K
- BDRX 16.1K
- Earning Date
- SNAX 11-13-2024
- BDRX 09-30-2024
- Dividend Yield
- SNAX N/A
- BDRX N/A
- EPS Growth
- SNAX N/A
- BDRX N/A
- EPS
- SNAX N/A
- BDRX N/A
- Revenue
- SNAX $19,364,939.00
- BDRX $104,895.00
- Revenue This Year
- SNAX $30.31
- BDRX N/A
- Revenue Next Year
- SNAX N/A
- BDRX N/A
- P/E Ratio
- SNAX N/A
- BDRX N/A
- Revenue Growth
- SNAX N/A
- BDRX N/A
- 52 Week Low
- SNAX $0.55
- BDRX $3.50
- 52 Week High
- SNAX $2.33
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- SNAX 50.42
- BDRX 47.13
- Support Level
- SNAX $0.70
- BDRX $4.13
- Resistance Level
- SNAX $0.77
- BDRX $4.60
- Average True Range (ATR)
- SNAX 0.08
- BDRX 0.25
- MACD
- SNAX 0.01
- BDRX 0.04
- Stochastic Oscillator
- SNAX 45.54
- BDRX 55.15
About SNAX Stryve Foods Inc.
Stryve Foods Inc is a healthy snacking company that manufactures, markets, and sells differentiated healthy snacking products. The company offers convenient snacks that are lower in sugar and carbohydrates and higher in protein than other snacks.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.